ProMIS Neurosciences Inc (PMN): Next-Year EPS Estimate 25.36%
As of 2026-09-11, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 25.36%. Featured in our EPS revision report on 2026-07-30.
On 2026-08-21, analyst consensus for PMN's next-year EPS growth shifted from 28.61% to 25.36% — a negative change of 3.25 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at 77.42%.
What's Driving This
PMN's rise is primarily supported by a 25.36% next-year EPS growth estimate flagged on 2026-08-21, which remains the current consensus. Recent quarterly results and earnings call highlights—specifically zero ARIA-E cases in the PM
Generated 2026-08-29 from news as of 2026-08-29
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.36%
- EPS growth this year
- 77.42%
- EPS next quarter (est)
- -$1.27
- Last price
- $13.56
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-11 | 25.36% | 77.42% | -$1.27 | $13.56 |
| 2026-09-10 | 25.36% | 77.42% | -$1.27 | $13.40 |
| 2026-09-09 | 25.36% | 77.42% | -$1.27 | $14.36 |
| 2026-09-08 | 25.36% | 77.42% | -$1.27 | $12.53 |
| 2026-09-07 | 25.36% | 77.42% | -$1.27 | $12.60 |
| 2026-09-06 | 25.36% | 77.42% | -$1.27 | $12.60 |
| 2026-09-04 | 25.36% | 77.42% | -$1.27 | $12.60 |
| 2026-09-03 | 25.36% | 77.42% | -$1.27 | $12.90 |
| 2026-09-02 | 25.36% | 77.42% | -$1.27 | $13.98 |
| 2026-09-01 | 25.36% | 77.42% | -$1.27 | $13.35 |
| 2026-08-31 | 25.36% | 77.42% | -$1.27 | $13.07 |
| 2026-08-30 | 25.36% | 77.42% | -$1.27 | $13.78 |
| 2026-08-29 | 25.36% | 77.42% | -$1.27 | $13.78 |
| 2026-08-28 | 25.36% | 77.42% | -$1.27 | $13.78 |
| 2026-08-27 | 25.36% | 77.42% | -$1.27 | $13.99 |
| 2026-08-26 | 25.36% | 77.42% | -$1.27 | $14.46 |
| 2026-08-25 | 25.36% | 77.42% | -$1.27 | $15.36 |
| 2026-08-24 | 25.36% | 77.42% | -$1.27 | $14.80 |
| 2026-08-23 | 25.36% | 77.42% | -$1.27 | $14.51 |
| 2026-08-21 | 25.36% | 77.42% | -$1.27 | $14.51 |
| 2026-08-14 | 28.61% | 77.92% | -$1.39 | $14.73 |
| 2026-08-13 | 27.14% | 76.67% | -$1.38 | $14.79 |
| 2026-08-12 | 27.14% | 76.67% | -$1.38 | $14.50 |
| 2026-08-11 | 27.14% | 76.67% | -$1.38 | $14.97 |
| 2026-08-10 | 27.14% | 76.67% | -$1.38 | $14.72 |
| 2026-08-09 | 27.14% | 76.67% | -$1.38 | $14.71 |
| 2026-08-07 | 27.14% | 76.67% | -$1.38 | $14.71 |
| 2026-08-06 | 27.14% | 76.67% | -$1.38 | $13.33 |
| 2026-08-05 | 27.14% | 76.67% | -$1.38 | $13.48 |
| 2026-08-04 | 27.14% | 76.67% | -$1.38 | $13.57 |
Reports Featuring PMN
Recent News
- ProMIS Neurosciences Inc (PMN) (Q2 2026) Earnings Call Highlights: Zero ARIA-E Cases and ...GuruFocus.com
- ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate HighlightsGlobeNewswire
- ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer's DiseaseGlobeNewswire
Screen Performance
Aggregate stats across all 2037 tickers our top-EPS-revision screen has flagged over the past 163 days.
- Median return since detection
- +0.9%
- % of tickers in the green
- 52%
- Median return on winners
- +21.4%
- Large revisions captured
- 1705
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is ProMIS Neurosciences Inc's next-year EPS growth estimate?▾
As of 2026-09-11, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 25.36%, based on analyst consensus.
When was the latest EPS estimate revision for PMN?▾
The most recent revision occurred on 2026-08-21, when analysts adjusted the next-year EPS growth estimate from 28.61% to 25.36%.
What sector and industry does ProMIS Neurosciences Inc belong to?▾
ProMIS Neurosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. ProMIS Neurosciences Inc (PMN) appears here because it was detected by our daily top-EPS-revision-performer screen.